Medications News

Parkinson Diagnosis Associated with Artistic Creativity

July 15th, 2014
New research suggests that many individuals with Parkinson’s disease display exceptional artistic acumen. Professor Rivka Inzelberg of Tel Aviv University (TAU) documented the extraordinary creativity of Parkinson's patients two years ago in a review for the journal Behavioral Neuroscience. Now, in a new ...

Sleep Disturbances Plague Most Parkinson’s Patients

July 12th, 2014
Up to 70 percent of patients with Parkinson’s disease (PD) experience sleep difficulties that negatively affect their quality of life, according to a new review in the Journal of Parkinson’s Disease. For example, some patients have unhealthy sleep/wake patterns, such as having a difficult time ...

Neuroscience Discovery May Accelerate Brain Research

July 11th, 2014
Researchers have determined that the human brain operates much the same whether active or at rest. Experts believe this finding will provide a better understanding of schizophrenia, bipolar disorder, and other serious mental health conditions that afflict an estimated 13.6 million Americans. Poor ...

Dead Ends in Alzheimer’s Research Expose Need for New Drug Studies

July 7th, 2014
A review of existing research for pharmacological answers to Alzheimer’s disease (AD) catalogs a litany of failures and calls for an aggressive re-dedication to increase the AD drug development pipeline. The first of its kind research study is published in the journal Alzheimer's Research & Therapy. "Our ...

CBT Can Help Reduce Seizures In Conversion Disorder

July 4th, 2014
Cognitive-behavioral therapy appears to help reduce seizures among individuals with psychogenic nonepileptic seizures (PNES), a conversion disorder affecting over 400,000 Americans. The study, led by W. Curt LaFrance Jr., M.D., M.P.H., director of neuropsychiatry and behavioral neurology at Rhode Island Hospital, is published ...

CBT With Drug Therapy Cuts Depression Relapse in Kids Compared to Meds Alone

July 3rd, 2014
A combination of cognitive-behavioral therapy along with medication enhances treatment for children and adolescents suffering from depression. In a new clinical trial, investigators discovered depression relapse rates were substantially lower in a group of youths who received both forms of treatment versus medication ...

St. John’s Wort Interactions Can Be Dangerous

July 1st, 2014
New research discovers that combining St. John's wort, the leading complementary and alternative treatment for depression in the United States, with commonly prescribed drugs, can lead to dangerous side effects. Wake Forest Baptist Medical Center investigators report that the herbal supplement can reduce ...

Study Finds No Link Between Insomnia, High Blood Pressure

June 26th, 2014
As more than 30 percent of Americans deal with difficulty falling asleep, at least they don't have to worry that their insomnia being associated with high blood pressure. The new findings should relieve concerns of the medical consequences of insomnia on the cardiovascular ...

More Benefits Found In Deep Brain Stimulation for Parkinson’s

June 26th, 2014
While it is well-recognized that deep brain stimulation (DBS) improves motor symptoms of patients with early and advanced Parkinson's disease (PD), new research finds that DBS also reduces the number and severity of non motor symptoms. "Non-motor features are common in PD patients, ...

Growth Hormone May Lead to Depression in Kids

June 24th, 2014
New research discovers that children treated with growth hormone (GH) may become depressed and withdrawn over time. Thus, although hormonal treatments may work to help a child become taller, the unintended consequences of psychosocial issues must be considered. Study results were presented at the ...